# Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ustekinumab-treatment-for-moderate-to-severe-plaque-psoriasis-eight-year-real/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marco Galluzzo,S. D’Adamio,Dionisio Silvaggio,Paul Lombardo,Antonio Massaro,Colin Gerard Egan,Luca Bianchi,Marina Talamonti |
| Citations | 23 |
| DOI | 10.1080/14712598.2020.1684472 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2981674377 |
| PMID | 31640431 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Antonio Massaro](https://scholariq.org/researchers/antonio-massaro/)

## Paper journal

- [Expert Opinion on Biological Therapy](https://scholariq.org/journals/expert-opinion-on-biological-therapy/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.